Conceptus, Inc. Reports Sharply Higher Second Quarter Net Sales of $25.7 Million

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Conceptus, Inc. (Nasdaq: CPTS), developer of the Essure® procedure, the first and only non-incisional permanent birth control method available, today reported financial results for the three and six months ended June 30, 2008.
MORE ON THIS TOPIC